Delayed respiratory depression after accidental risperidone overdose

Paediatric and Perinatal Drug Therapy

Volumn 8, Issue 4, 2008, Pages 154-156

  Satish, H P ^a   Payne, H ^b   Potter, F ^b   Nunn, A J ^b   Brodbelt, K ^b  

^a LEIGHTON HOSPITAL   (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Overdose; Pipette; Respiratory depression; Risperidone

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; RISPERIDONE;

ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; AUTISM; BEHAVIOR DISORDER; CASE REPORT; CONVALESCENCE; DISEASE SEVERITY; DRUG LABELING; DRUG OVERDOSE; EMERGENCY WARD; EXTUBATION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MALE; MEDICATION ERROR; MENTAL HOSPITAL; OFF LABEL DRUG USE; PEDIATRIC HOSPITAL; PRESCRIPTION; PSYCHOLOGIC ASSESSMENT; RESPIRATION DEPRESSION; RESPIRATORY TRACT INTUBATION; SCHOOL CHILD; TREATMENT OUTCOME; VISUAL HALLUCINATION;

EID: 49449112765     PISSN: 14630095     EISSN: None     Source Type: Journal    
DOI: 10.1185/146300908X254224     Document Type: Article

References (9)

1. Schillevoort I, de Boer A, Herings RM et al. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Ann Pharmacother 201;35:1517-1522.
2. McCracken JT, McGough J, Shah B et al. Risperidone in children with autism and serious behavioral problems. New Engl J Med 2002;347:314-321.
3. Chavez B. Role of risperidone in children with autism spectrum disorder. Ann Pharmacother 2006;40:909-916.
4. Reyes M, Olah R, Csaba K, Augustyns I, Eerdekens M. Long- term safety and efficacy of risperidone in children with disruptive behaviour disorders. Results of a 2-year extension study. Eur Child Adolesc Psychiatry 2006;15:97-104.
5. Antia SX, Sholevar EH, Baron DA. Overdoses and ingestions of second-generation antipsychotics in children and adolescents. J Child Adolesc Psychopharmacol 2005;15:970-985.
6. Jesner OS, Aref-Adib M, Coren E. Risperidone for autism spectrum disorder. Cochrane Database Syst Rev 2007: CD005040.
7. Morgan S, Taylor E. Antipsychotic drugs in children with autism. BMJ 2007;334:1069-1070.
8. Food and Drug Administration. Risperidone labelling.www.fda.gov/cder/foi/ label/2006/021444s008s015,020588s024s028s029,020272s036s041lbl.pdf
9. http://www.va.gov/NCPS/alerts/Pipette.doc